Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20120915010841N25Phase 3Completed
Phase 3, randomised, open-label trial of bupivacaine (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Time to maximum sensory block, Quality of sensory block and 2 more. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20120915010841N25.